Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.2 (
acetyl-CoA carboxylase
)
2,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
AMP-activated protein kinase (AMPK) regulates both glycogen and lipid metabolism functioning as an intracellular energy sensor. In this study, we identified a 160-kDa protein in mouse skeletal muscle lysate by using a glutathione-S-transferase (GST)-AMPK fusion protein pull-down assay. Mass spectrometry and a Mascot search revealed this protein to be a
glycogen debranching enzyme
(
GDE
). The association between AMPK and
GDE
was observed not only in the overexpression system but also endogenously. Next, we showed the beta1-subunit of AMPK to be responsible for the association with
GDE
. Furthermore, experiments using deletion mutants of the beta1-subunit of AMPK revealed amino acids 68-123 of the beta1-subunit to be sufficient for
GDE
binding. W100G and K128Q, both beta1-subunit mutants, are reportedly incapable of binding to glycogen, but both bound
GDE
, indicating that the association between AMPK and
GDE
does not involve glycogen. Rather, the AMPK-
GDE
association is likely to be direct. Overexpression of amino acids 68-123 of the beta1-subunit inhibited the association between endogenous AMPK and
GDE
. Although
GDE
activity was unaffected, basal phosphorylation and kinase activity of AMPK, as well as phosphorylation of
acetyl-CoA carboxylase
, were significantly increased. Thus it is likely that the AMPK-
GDE
association is a novel mechanism regulating AMPK activity and the resultant fatty acid oxidation and glucose uptake.
...
PMID:Glycogen debranching enzyme association with beta-subunit regulates AMP-activated protein kinase activity. 1588 29